Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Otolaryngol Head Neck Surg ; 135(3): 427-33, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16949977

ABSTRACT

OBJECTIVE: The ultrastructural characteristics of new bone and cartilage, induced at the site of cricoid cartilage defects treated with rhBMP-2 in rabbits, were investigated. STUDY DESIGN AND SETTING: A cricoid defect model was used. Fifteen rabbits were randomly and equally divided into 3 groups. Four rabbits from each group were treated with rhBMP-2, while one rabbit from each group was used as control. The rabbits were killed 1, 2, or 4 weeks after surgery. The healing pattern of the laryngeal wound was evaluated by light and transmission electron microscopy. RESULTS: Mineralized collagen type I matrix, osteoblasts, and osteoclast-like cells were present as early as 1 week after surgery. Well-structured bone trabeculas and growth plate-like structures were present 4 weeks after surgery. CONCLUSION: Intramembranous and endochondral osteogenesis take place at the site of cricoid cartilage defects treated with rhBMP-2. Progenitor cells of cricoid perichondrium form a growth plate-like structure similar to the epiphyseal growth plate. SIGNIFICANCE: This study reveals the pattern of BMP-2-induced repair of airway cartilage defects.


Subject(s)
Bone Morphogenetic Proteins/therapeutic use , Chondrogenesis/drug effects , Cricoid Cartilage/drug effects , Growth Plate/drug effects , Laryngeal Diseases/drug therapy , Recombinant Proteins/therapeutic use , Transforming Growth Factor beta/therapeutic use , Animals , Bone Morphogenetic Protein 2 , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Chondrocytes/drug effects , Chondrocytes/pathology , Collagen Type I/drug effects , Collagen Type I/ultrastructure , Cricoid Cartilage/pathology , Disease Models, Animal , Growth Plate/pathology , Laryngeal Diseases/pathology , Male , Microscopy, Electron, Transmission , Osteoblasts/drug effects , Osteoblasts/pathology , Osteoclasts/drug effects , Osteoclasts/pathology , Osteogenesis/drug effects , Rabbits , Random Allocation , Time Factors , Wound Healing/drug effects
2.
Wound Repair Regen ; 13(3): 341-9, 2005.
Article in English | MEDLINE | ID: mdl-15953055

ABSTRACT

We determined the origin of new cartilage and new bone induced by recombinant human bone morphogenetic protein-2 (rhBMP-2) at the site of cricoid cartilage defects in rabbits randomly divided into eight groups. The cricoid cartilage was split vertically along the anterior midline and a strip was excised from the anterior part of the cricoid cartilage in all rabbits. The perichondrium from the anterior part of the cricoid cartilage was trimmed off in four groups; two groups treated with rhBMP-2 and two control groups. In four other groups, the anterior perichondrium was detached and used as a flap with two groups treated with rhBMP-2 and two groups serving as controls. The rabbits were killed 1 week or 4 weeks after surgery. The larynges were removed, fixed and sectioned, and the sections were stained for light microscopy using various cytochemical and immunological techniques. New cartilage was only present close to the host perichondrium adherent to cricoid cartilage in rabbits treated with rhBMP-2. New bone was present 4 weeks after surgery, although calcified matrix and alkaline phosphatase activity could be detected at the site of cricoid defects as early as 1 week after surgery. The cell proliferation marker Ki-67 was strongly expressed in granulation tissue and bone marrow, and it was moderately expressed in muscles adjacent to the cricoid cartilage in rhBMP-2-treated specimens. BMP receptors were strongly expressed in cartilage and moderately expressed in adjacent muscles. We conclude that new cartilage originates from the mesenchymal progenitor cells of host perichondrium adherent to cricoid cartilage in rabbits treated with rhBMP-2. New bone may originate from local muscle.


Subject(s)
Biological Factors/administration & dosage , Bone Morphogenetic Proteins/administration & dosage , Chondrogenesis/drug effects , Cricoid Cartilage/drug effects , Transforming Growth Factor beta/administration & dosage , Wounds and Injuries/drug therapy , Administration, Topical , Animals , Bone Morphogenetic Protein 2 , Cell Proliferation/drug effects , Male , Osteogenesis/drug effects , Rabbits , Regeneration/drug effects
3.
Int J Pediatr Otorhinolaryngol ; 69(9): 1239-46, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15888347

ABSTRACT

OBJECTIVE: The study evaluated the possible differences in the repair of cricoid cartilage defects treated with recombinant human BMP-2 in young and adult rabbits. METHODS: A cricoid defect rabbit model was used. Thirty rabbits were randomly divided into eight groups. Two groups of young rabbits and two groups of adult rabbits were treated with rhBMP-2 delivered on an absorbable collagen sponge, while the other two groups of young rabbits and two groups of adult rabbits were used as controls. The rabbits were killed at 1 week or 4 weeks after surgery. A histomorphometric analysis and an evaluation of the expression of collagen types I, II, and X, and proliferating cell nuclear antigen as well as a study of distribution of calcified matrix, were performed. RESULTS: rhBMP-2 induced a marked chondrogenesis in both experimental age groups. However, in young rabbits the newly formed cartilage appeared more elongate, and the length of perichondrium involved was greater. The host cricoid cartilage of adult rabbits was calcified in large areas and displayed a strong matrix expression of collagen type X as well as collagen type I in the perichondrium, compared to the cricoid of young rabbits. In spite of these differences no immunohistochemical differences were found in the newly formed cartilage of both age groups treated with rhBMP-2. The cricoid cartilage defect was filled with new bone at 4 weeks in both age groups treated with rhBMP-2. New bone tissue had a well-defined trabecular structure. CONCLUSIONS: rhBMP-2 triggers appositional cartilage growth from the cricoid perichondrium of young rabbits more easily than from that of adult rabbits. The new bone induced by rhBMP-2 showed a similar immunohistochemical and morphological pattern in both age groups of rabbits.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Chondrogenesis/drug effects , Cricoid Cartilage/drug effects , Cricoid Cartilage/injuries , Transforming Growth Factor beta/pharmacology , Wound Healing/drug effects , Adult , Age Factors , Animals , Bone Morphogenetic Protein 2 , Bone Morphogenetic Proteins/administration & dosage , Cell Proliferation/drug effects , Collagen Type I/biosynthesis , Collagen Type II/biosynthesis , Collagen Type X/biosynthesis , Cricoid Cartilage/physiology , Humans , Immunohistochemistry , Ki-67 Antigen/biosynthesis , Male , Osteogenesis/drug effects , Rabbits , Random Allocation , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Transforming Growth Factor beta/administration & dosage , Wounds and Injuries/drug therapy
4.
Acta Otolaryngol ; 124(5): 612-5, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15267181

ABSTRACT

OBJECTIVE: Bone morphogenetic protein-2 offers potential benefits for cartilage regeneration. We investigated the effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the regeneration of laryngeal cartilage and respiratory epithelium in a rabbit model. MATERIAL AND METHODS: We used a cricoid defect rabbit model. Twenty-four rabbits were randomly divided into four equal groups. Two groups were treated with 5 microg of rhBMP-2 delivered on an absorbable collagen sponge and the other two groups were used as controls. One group of treated rabbits and one group of control rabbits were euthanized 1 week after surgery, while the others were euthanized 4 weeks after surgery. The healing pattern of the laryngeal wound was evaluated by means of histomorphometry. RESULTS: Regeneration of both the epithelial layer and cartilage was significantly better in rabbits treated with rhBMP-2. Four weeks after surgery, the cricoid cartilage defect was completely repaired by new cartilage and new bone in rabbits treated with rhBMP-2. Furthermore, the lining respiratory epithelium healed more rapidly in treated rabbits. CONCLUSION: rhBMP-2, delivered via an absorbable collagen sponge, induces complete regeneration and repair of rabbit cricoid cartilage defects. It also induces faster relining and regeneration of airway epithelium than in control rabbits.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Cricoid Cartilage/drug effects , Regeneration/drug effects , Transforming Growth Factor beta/pharmacology , Animals , Bone Morphogenetic Protein 2 , Cricoid Cartilage/physiology , Male , Models, Animal , Rabbits , Random Allocation , Recombinant Proteins/pharmacology , Wound Healing/drug effects
5.
Wound Repair Regen ; 12(3): 346-50, 2004.
Article in English | MEDLINE | ID: mdl-15225213

ABSTRACT

We examined the structural characteristics of repair tissue induced by recombinant human bone morphogenetic protein-2 in a rabbit model of laryngotracheal reconstruction. Twenty-four New Zealand White rabbits were randomly divided into four groups of six rabbits. Two groups were treated with recombinant human bone morphogenetic protein-2 delivered on an absorbable collagen sponge, while two groups were used as controls. Rabbits were euthanized at 1 and 4 weeks after surgery. The larynx was removed, fixed, and sectioned. The sections were stained with hematoxylin-eosin, safranine O/fast green, and immunostained with an antibody for tissue inhibitor of metalloproteinases-1. In rabbits treated with bone morphogenetic protein-2, the defects were filled with new cartilage and bone at 4 weeks after surgery. There were no discontinuities or gaps at the margins of the cartilage defects. Proteoglycans were synthesized in new cartilage in rabbits treated with bone morphogenetic protein-2, and were present 4 weeks after surgery. The general aspects of the vascular pattern and the pattern of tissue inhibitor of metalloproteinases-1 expression were similar in control and treated rabbits, both 1 week and 4 weeks after surgery. The repair tissue induced by recombinant human bone morphogenetic protein-2 consisted of new cartilage and bone perfectly integrated with host tissue at the site of the cricoid cartilage defects. This new cartilage was able to mature and produce proteoglycans.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Cricoid Cartilage/drug effects , Growth Substances/pharmacology , Regeneration/drug effects , Transforming Growth Factor beta/pharmacology , Wound Healing/drug effects , Animals , Bone Morphogenetic Protein 2 , Bone Regeneration/drug effects , Cricoid Cartilage/injuries , Cricoid Cartilage/physiopathology , Humans , Male , Models, Animal , Neovascularization, Physiologic/physiology , Proteoglycans/analysis , Proteoglycans/biosynthesis , Rabbits , Recombinant Proteins , Tissue Inhibitor of Metalloproteinase-1/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...